Bristol Myers Squibb Co. Stock Falls Monday, Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) slipped 0.58% to $68.90 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.07% to 4,048.42 and the Dow Jones Industrial Average rising 0.12% to 33,431.44. Bristol Myers Squibb Co. closed $12.54 below its 52-week high ($81.44), which the company achieved on December 1st.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 1.00% to $155.56, Pfizer Inc. (PFE) fell 0.10% to $41.11, and Abbott Laboratories (ABT) fell 1.63% to $102.75. Trading volume (6.8 M) remained 1.1 million below its 50-day average volume of 7.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 6, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 06, 2023 16:41 ET (21:41 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.